Skip to main content
Back to Top


Let's Discuss: Tools of the Trade: Multicomponent Interventions to Increase Cancer Screening”

Content on this page is provided for reference purposes only. It is no longer maintained and may now be outdated.

I simply cannot imagine better timing for today’s cyber-seminar – following so closely up the release of the Community Preventive Services Task Force (CPSTF) recommendation regarding the effectiveness of multicomponent interventions to increase cancer screening.  And certainly I am very grateful to the wonderful team to talk about the Community Guide as well as the promise and pitfalls of mulit-level interventions in cancer control!

The CPSTF recommendation is based on strong evidence of effectiveness in increasing screening use for breast, cervical, or colorectal cancers. Multicomponent interventions or using a combination of interventions, to increase cancer screening may be coordinated through healthcare systems, delivered in community settings, or both.

We are grateful to Yinan and Devon for thoughtfully walking us through the newly-relaunched Community Guide and how one can use it not just to strengthen programming, but also speak to

In turn, Heather so beautifully highlighted how the Guide to Community Preventive Services (The Community Guide) is an instrumental part of the NYSDOH BCPC’s comprehensive approach to increasing screenings for breast, cervical, and colorectal cancers (as featured in this Community Guide in Action Story).

And now we wish to open the discussion to you:

  • Do you have questions for any of our presenters?
  • Does your own work relate to cancer screening programs? Do you have any “lessons learned” or best practices to share?
  • What are some of the challenges and opportunities you see in regards to multi-level interventions? How can NCI and CDC address these issues?


What a great session and

What a great session and thank you to the speakers as well as the participants for the lively exchange!

The questions kept flooding in, and these were the ones that we did not get a change to answer - Heather, Devon and Yinan will be chiming in with their responses, but we hope that you will add your persepctices as well.  

  • Who pays for the deductibles and co pays­?
  • ­Make It Your Own (MIYO) could be another good resource for people to create small media material around breast, cervical and colorectal cancer.­
  • ­At the USF PRC, we are currently planning interventions to increase CRC screning in Florida and will appreciate it if you could share your evaluation materials? ­
  • ­Do you know of media resources (fliers, videos, etc) in different languages for colorectal cancer screening?­
  • ­Where can we find evidence gaps that Yinan mentioned?­
  • How to do you reach various ethniticy groups in your area. We find even our free screenings we offer we do not reach certain ethnicity groups we would like to.  Not sure if like you mentioned it is due to fear or embarrassed to come.
  • ­We have a One Voice Free Breast Cancer Screening Program for uninsured women at University of Maryland St Joseph Medical Center. We are able to provide both screening and diagnostic mammograms ­
  • ­­Different cultural groups have different engagement. I have found Burmese, Nepali patients to be eager to engage in screening, however, African American patients, Arabic and Somali speaking patients have not. Have you encountered evidence for reaching thes­e groups?

Hi.  I work with Heather

Hi.  I work with Heather Dacus and want to offer responses to some of the questions listed above.  The responses are in the attached Word document because I wanted to embedd some links to resources, but was unable to do so in this text box. 

Media resources in different language for colorectal cancer screening

Reaching various ethnic groups

Reaching African American, Arab and Somali patients





Hi, Margaret - thanks again

Hi, Margaret - thanks again to you and others at CDC and NCI for inviting us to present on our work.  It was an honor to be able to present along with Yinan and Devon.  The Community Guide has been an invaluable resource to us. 

Great questions from everyone!  Here are some responses, and I'll log in again later this week.

One person mentioned the MIYO system, and we couldn't agree more that it is a valuable resource.  We conducted a webinar for state partners on the MIYO system and were honored to have the creators of MIYO present.  That webinar is archived here:

We got a lot of questions about our Academic Detailing and Practice Facilitation project conducted with our contractor/partner at the Upstate Medical University at State University of New York in Syracuse.  An article addressing the first year of the work is available at, and the course for clinicians/practices I mentioned is available to view at

I hope this is helpful information.

We’ll draft some answers for

We’ll draft some answers for the questions regarding racial and ethnic minorities. The answers will be a reflection of what evidence we have, with list of studies that could provide further info - so will be happy to share that with everyone. 

For the question on evidence gaps, here is our answer: 

You will find summaries for each of the three CPSTF findings on the Community Guide website. The list of evidence gaps for each review can be found under the tab, “What the Task Force Found.”


One of the callers had a

One of the callers had a question regarding multi component interventions in lung cancer screening.  As you are aware, there is little in the way of evidence based interventions for lung cancer that do not focus on tobacco cessation. The PA Divison of Cancer Prevention and Control partnered with the Division of Tobacco Prevention and Control and its Southeast Regional Primary Tobacco Contractor (Health Promotion Council of SE PA)  to integrate a lung cancer screening program into an existing hospital based tobacco cessation program (group education).  The Tobacco Treatment Specialist, a respiratory therapist, identified and navigated patients through the screening process (reducing structural barriers). Results: 45 patients met criteria, 26 met with a healthcare provider to discuss risks and benefits, 20 received LDCT and 13 required follow-up screening. PA will be submitting this as a success story to CDC and hopes to replicate this program in other hospital based tobacco cessation programs.


Followers of this discussion

Followers of this discussion might be interested in the recent Funding Opportunity Announcement, "Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests [PA-17-495]"

This Funding Opportunity Announcement (FOA) encourages applications that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, cervical, colorectal, or lung cancers. Improving follow-up to abnormal screening tests is dependent on factors at the patient, provider, clinical team, clinic, healthcare institution, and community setting levels. Appropriate applications for this FOA should propose to intervene at two or more levels, and measure outcomes at three or more levels, while accounting for interactions that occur between and across levels.

More information about this FOA is available here: PA-17-495 (R01)